Page last updated: 2024-08-21

alpha-aminopyridine and Cancer of Nasopharynx

alpha-aminopyridine has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chau, NG; Haddad, RI; Tishler, RB	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cancer of Nasopharynx

Article	Year
Highlights in Head and Neck Cancer. JAMA oncology, 2017, 04-01, Volume: 3, Issue:4 Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Clinical Trials as Topic; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Molecular Targeted Therapy; Morpholines; Nasopharyngeal Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Programmed Cell Death 1 Receptor; Squamous Cell Carcinoma of Head and Neck	2017

Article

Year

Highlights in Head and Neck Cancer.

JAMA oncology, 2017, 04-01, Volume: 3, Issue:4

Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Clinical Trials as Topic; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Molecular Targeted Therapy; Morpholines; Nasopharyngeal Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Programmed Cell Death 1 Receptor; Squamous Cell Carcinoma of Head and Neck

2017